Question 1

What is Contineum Therapeutics, Inc. (CTNM)'s latest shareholders’ equity?

Accepted Answer

Contineum Therapeutics, Inc. (CTNM)'s shareholders’ equity for FY2024 was $198.1M, as reported in its SEC filings.

Question 2

How has Contineum Therapeutics, Inc. (CTNM)'s shareholders’ equity changed year over year?

Accepted Answer

CTNM's shareholders’ equity went from -$67.9M in FY2023 to $198.1M in FY2024, an increase of 391.5%.

Question 3

What is the highest shareholders’ equity Contineum Therapeutics, Inc. (CTNM) reported over FY2023–FY2024?

Accepted Answer

The highest reported shareholders’ equity over FY2023–FY2024 was $198.1M, in FY2024.

Question 4

What years does this shareholders’ equity history cover?

Accepted Answer

This page shows CTNM's shareholders’ equity for each fiscal year from FY2023 to FY2024, drawn from SEC XBRL filings.

Fiscal year	Value	YoY
FY2024	$198.1M	+391.5%
FY2023	-$67.9M	—

Contineum Therapeutics, Inc. (CTNM) Shareholders’ equity 2023–2024

More CTNM financial trends